• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肌炎患者局部蜂窝织炎继发脓性肌炎:一例报告及皮肌炎感染并发症综述

Pyomyositis Secondary to Localized Cellulitis in a Dermatomyositis Patient: A Case Report and Review of Infectious Complications in Dermatomyositis.

作者信息

Zhang Xingwei, Lyu Xiaoyan

机构信息

Department of Dermatology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.

Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, People's Republic of China.

出版信息

Clin Cosmet Investig Dermatol. 2023 Aug 11;16:2201-2209. doi: 10.2147/CCID.S417772. eCollection 2023.

DOI:10.2147/CCID.S417772
PMID:37588111
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10426407/
Abstract

Dermatomyositis (DM) is an autoimmune disorder characterized by proximal muscle weakness and distinct cutaneous features. Unfortunately, infection is a frequent and potentially life-threatening complication in patients with DM. Here, we present a case of pyomyositis in a patient with DM resulting from localized cellulitis. The patient also presented with subcutaneous calcification nodules and dermatomyositis-associated lipodermatosclerosis nodules. To our knowledge, there have been no reports of pyomyositis in patients with DM to date. Furthermore, we reviewed the infectious complications related to DM and polymyositis (PM). We found that idiopathic inflammatory myopathy (IIM) patients exhibit a considerable infection-related mortality rate, ranging from 4.3% to 7.2%. In IIM, infections were identified as the primary cause of mortality in a substantial proportion of cases, accounting for 22.0-83.3% of deaths. These findings have implications for the importance of identifying and managing infections in IIM patients and suggest the need for further research into infection-related complications in these patients.

摘要

皮肌炎(DM)是一种自身免疫性疾病,其特征为近端肌无力和独特的皮肤表现。不幸的是,感染是DM患者常见且可能危及生命的并发症。在此,我们报告一例DM患者因局部蜂窝织炎导致的脓性肌炎病例。该患者还出现了皮下钙化结节和皮肌炎相关的脂膜炎性硬化结节。据我们所知,迄今为止尚无DM患者发生脓性肌炎的报道。此外,我们回顾了与DM和多发性肌炎(PM)相关的感染性并发症。我们发现,特发性炎性肌病(IIM)患者的感染相关死亡率相当高,在4.3%至7.2%之间。在IIM中,感染在相当一部分病例中被确定为主要死因,占死亡病例的22.0 - 83.3%。这些发现凸显了识别和管理IIM患者感染的重要性,并表明有必要对这些患者的感染相关并发症进行进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c98/10426407/50e018324cf4/CCID-16-2201-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c98/10426407/5fdd14ac9f23/CCID-16-2201-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c98/10426407/2b952c470b8c/CCID-16-2201-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c98/10426407/50e018324cf4/CCID-16-2201-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c98/10426407/5fdd14ac9f23/CCID-16-2201-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c98/10426407/2b952c470b8c/CCID-16-2201-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c98/10426407/50e018324cf4/CCID-16-2201-g0003.jpg

相似文献

1
Pyomyositis Secondary to Localized Cellulitis in a Dermatomyositis Patient: A Case Report and Review of Infectious Complications in Dermatomyositis.皮肌炎患者局部蜂窝织炎继发脓性肌炎:一例报告及皮肌炎感染并发症综述
Clin Cosmet Investig Dermatol. 2023 Aug 11;16:2201-2209. doi: 10.2147/CCID.S417772. eCollection 2023.
2
Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort.一个未经选择的完整挪威特发性炎性肌病队列中的生存率和癌症风险
Semin Arthritis Rheum. 2015 Dec;45(3):301-8. doi: 10.1016/j.semarthrit.2015.06.005. Epub 2015 Jun 17.
3
Polymyositis and dermatomyositis: ocular manifestations and potential sight-threatening complications.多发性肌炎和皮肌炎:眼部表现及潜在致盲性并发症。
Rheumatol Int. 2022 Jul;42(7):1119-1131. doi: 10.1007/s00296-021-05035-7. Epub 2021 Oct 21.
4
Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies.根据 2017 年欧洲抗风湿病联盟/美国风湿病学会成人和青少年特发性炎性肌病分类标准对韩国多发性肌炎和皮肌炎患者进行 Bohan 和 Peter 标准再分类。
Korean J Intern Med. 2021 Mar;36(2):441-446. doi: 10.3904/kjim.2019.149. Epub 2019 Dec 30.
5
The spectrum of idiopathic inflammatory myopathies in South Africa.南非特发性炎性肌病的谱系
Clin Rheumatol. 2021 Apr;40(4):1437-1446. doi: 10.1007/s10067-020-05048-w. Epub 2020 Mar 24.
6
Idiopathic inflammatory myopathy: clinicopathological observations in the Indian population.特发性炎性肌病:印度人群的临床病理观察
Br J Rheumatol. 1992 Dec;31(12):835-9. doi: 10.1093/rheumatology/31.12.835.
7
Paraneoplastic dermatomyositis associated with urothelial cancer: report of a case and systematic review of the literature.与尿路上皮癌相关的副肿瘤性皮肌炎:一例报告及文献系统综述
Front Oncol. 2023 Oct 31;13:1223627. doi: 10.3389/fonc.2023.1223627. eCollection 2023.
8
Investigation into the cause of mortality in 49 cases of idiopathic inflammatory myopathy: A single center study.49例特发性炎性肌病死亡原因调查:一项单中心研究。
Exp Ther Med. 2016 Mar;11(3):885-889. doi: 10.3892/etm.2016.3006. Epub 2016 Jan 18.
9
[Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].[多发性肌炎、皮肌炎和包涵体肌炎,疾病分类学方面]
Presse Med. 2003 Oct 25;32(35):1656-67.
10
Idiopathic inflammatory myopathies: a review.特发性炎性肌病:综述。
Intern Med J. 2021 Jun;51(6):845-852. doi: 10.1111/imj.15358.

引用本文的文献

1
Imaging features of juvenile dermatomyositis complicated by pyomyositis in a 12-year-old boy: A case report.一名12岁男孩患幼年皮肌炎合并脓性肌炎的影像学特征:病例报告
Radiol Case Rep. 2025 Mar 8;20(5):2540-2543. doi: 10.1016/j.radcr.2025.02.010. eCollection 2025 May.
2
Arthritis or an Adjacent Fascial Response? A Case Report of Combined Pyomyositis and Aseptic Arthritis.关节炎还是相邻筋膜反应?一例脓性肌炎合并无菌性关节炎的病例报告。
Case Rep Rheumatol. 2024 Jun 25;2024:2608144. doi: 10.1155/2024/2608144. eCollection 2024.

本文引用的文献

1
Long-term survival of patients with idiopathic inflammatory myopathies: anatomy of a single-centre cohort.特发性炎性肌病患者的长期生存:单中心队列分析。
Clin Exp Rheumatol. 2023 Mar;41(2):322-329. doi: 10.55563/clinexprheumatol/486yh4. Epub 2023 Mar 1.
2
Rituximab-induced hypogammaglobulinaemia in patients affected by idiopathic inflammatory myopathies: a multicentre study.利妥昔单抗诱导特发性炎性肌病患者低丙种球蛋白血症:一项多中心研究。
Clin Exp Rheumatol. 2023 Mar;41(2):285-290. doi: 10.55563/clinexprheumatol/790ihy. Epub 2023 Mar 1.
3
Risk of Early Infection in Idiopathic Inflammatory Myopathies: Cluster Analysis Based on Clinical Features and Biomarkers.
特发性炎性肌病早期感染风险:基于临床特征和生物标志物的聚类分析
Inflammation. 2023 Jun;46(3):1036-1046. doi: 10.1007/s10753-023-01790-w. Epub 2023 Feb 13.
4
Compounded sulfamethoxazole improved the prognosis of dermatomyositis patients positive with anti-melanoma differentiation-associated gene 5.复方磺胺甲噁唑改善抗黑色素瘤分化相关基因 5 阳性的皮肌炎患者的预后。
Rheumatology (Oxford). 2023 Sep 1;62(9):3095-3100. doi: 10.1093/rheumatology/kead034.
5
Intensive induction therapy combining tofacitinib, rituximab and plasma exchange in severe anti-melanoma differentiation-associatedprotein-5 antibody-positive dermatomyositis.在抗黑色素瘤分化相关蛋白 5 抗体阳性的皮肌炎中,联合托法替尼、利妥昔单抗和血浆置换进行强化诱导治疗。
Clin Exp Rheumatol. 2023 Mar;41(2):291-300. doi: 10.55563/clinexprheumatol/8kulbf. Epub 2023 Jan 24.
6
Clinical Characteristics and Associated Factors for Infection and in-Hospital Mortality in Inpatients with Polymyositis/Dermatomyositis in China: A Retrospective Study.中国多发性肌炎/皮肌炎住院患者感染及院内死亡的临床特征与相关因素:一项回顾性研究
Infect Drug Resist. 2023 Jan 17;16:289-299. doi: 10.2147/IDR.S392585. eCollection 2023.
7
Infection Risk in Patients with Dermatomyositis Associated with Anti-MDA5 Antibodies: A Historical Cohort Study.抗MDA5抗体相关皮肌炎患者的感染风险:一项历史性队列研究
Biomedicines. 2022 Dec 8;10(12):3176. doi: 10.3390/biomedicines10123176.
8
Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study.巴西成人皮肌炎患者的临床表现、结局和抗体谱:一项单中心纵向研究。
Adv Rheumatol. 2022 Nov 12;62(1):41. doi: 10.1186/s42358-022-00276-x.
9
Clinical characteristics of and risk factors for Pneumocystis jirovecii pneumonia in anti-melanoma differentiation-associated gene 5 (Anti-MDA5) antibody-positive dermatomyositis patients: a single-center retrospective study.抗黑色素瘤分化相关基因 5(Anti-MDA5)抗体阳性皮肌炎患者肺孢子菌肺炎的临床特征和危险因素:一项单中心回顾性研究。
Clin Rheumatol. 2023 Feb;42(2):453-462. doi: 10.1007/s10067-022-06403-9. Epub 2022 Oct 27.
10
Epidemiology, mortality and effectiveness of prophylaxis for Pneumocystis jiroveci pneumonia among rheumatic patients: a territory-wide study.风湿患者肺孢子菌肺炎的流行病学、死亡率和预防效果:全港研究。
Ann Clin Microbiol Antimicrob. 2021 Nov 11;20(1):78. doi: 10.1186/s12941-021-00483-2.